Chemed Corp (CHE) stock
CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/305% above fair value
$550.62+6.13 (+1.13%)
Close on Nov 11, 2026Market cap $7.17BP/E 26.3Yield 0.40%
Chemed ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Chemed's ebitda for the twelve months ending Sep 30, 2026 was $438.45M, up 5.4% year over year. For fiscal 2025 it was $403.09M, down 6.2% from the year before. Over ten years it grew 6.3% a year on average. The highest annual figure on record is $446.26M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $403.09M | -6.2% |
| FY2024 | Dec 31, 2024 | $429.54M | +7.0% |
| FY2023 | Dec 31, 2023 | $401.43M | -0.3% |
| FY2022 | Dec 31, 2022 | $402.67M | +0.1% |
| FY2021 | Dec 31, 2021 | $402.09M | -9.9% |
| FY2020 | Dec 31, 2020 | $446.26M | +47.5% |
| FY2019 | Dec 31, 2019 | $302.59M | +7.1% |
| FY2018 | Dec 31, 2018 | $282.50M | +90.0% |
| FY2017 | Dec 31, 2017 | $148.66M | -30.3% |
| FY2016 | Dec 31, 2016 | $213.39M | -2.1% |
| FY2015 | Dec 31, 2015 | $217.96M | +9.5% |
| FY2014 | Dec 31, 2014 | $199.02M | +22.3% |
| FY2013 | Dec 31, 2013 | $162.74M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $113.82M | +25.1% |
| Q2 FY2026 | Jun 30, 2026 | $106.19M | +25.9% |
| Q1 FY2026 | Mar 31, 2026 | $101.45M | -8.4% |
| Q4 FY2025 | Dec 31, 2025 | $116.98M | -9.8% |
| Q3 FY2025 | Sep 30, 2025 | $90.98M | -15.6% |
| Q2 FY2025 | Jun 30, 2025 | $84.34M | -18.8% |
| Q1 FY2025 | Mar 31, 2025 | $110.78M | +25.7% |
| Q4 FY2024 | Dec 31, 2024 | $129.71M | +2.2% |
| Q3 FY2024 | Sep 30, 2024 | $107.85M | +5.5% |
| Q2 FY2024 | Jun 30, 2024 | $103.84M | +22.7% |
| Q1 FY2024 | Mar 31, 2024 | $88.14M | +0.6% |
| Q4 FY2023 | Dec 31, 2023 | $126.93M | +32.3% |
| Q3 FY2023 | Sep 30, 2023 | $102.23M | +7.0% |
| Q2 FY2023 | Jun 30, 2023 | $84.65M | -21.0% |
| Q1 FY2023 | Mar 31, 2023 | $87.62M | -15.8% |
| Q4 FY2022 | Dec 31, 2022 | $95.94M | -14.6% |
| Q3 FY2022 | Sep 30, 2022 | $95.53M | -10.9% |
| Q2 FY2022 | Jun 30, 2022 | $107.17M | +22.0% |
| Q1 FY2022 | Mar 31, 2022 | $104.03M | +9.9% |
| Q4 FY2021 | Dec 31, 2021 | $112.38M | -28.7% |
| Q3 FY2021 | Sep 30, 2021 | $107.22M | +21.1% |
| Q2 FY2021 | Jun 30, 2021 | $87.82M | -17.9% |
| Q1 FY2021 | Mar 31, 2021 | $94.67M | +1.5% |
| Q4 FY2020 | Dec 31, 2020 | $157.60M | +72.1% |
| Q3 FY2020 | Sep 30, 2020 | $88.53M | +17.2% |
| Q2 FY2020 | Jun 30, 2020 | $106.91M | +41.0% |
| Q1 FY2020 | Mar 31, 2020 | $93.23M | +56.2% |
| Q4 FY2019 | Dec 31, 2019 | $91.55M | +18.1% |
| Q3 FY2019 | Sep 30, 2019 | $75.52M | +5.8% |
| Q2 FY2019 | Jun 30, 2019 | $75.82M | +11.7% |
| Q1 FY2019 | Mar 31, 2019 | $59.70M | -9.1% |
| Q4 FY2018 | Dec 31, 2018 | $77.51M | +18.3% |
| Q3 FY2018 | Sep 30, 2018 | $71.41M | +13.6% |
| Q2 FY2018 | Jun 30, 2018 | $67.89M | – |
| Q1 FY2018 | Mar 31, 2018 | $65.69M | +30.4% |
| Q4 FY2017 | Dec 31, 2017 | $65.50M | +5.9% |
| Q3 FY2017 | Sep 30, 2017 | $62.85M | – |
| Q2 FY2017 | Jun 30, 2017 | -$30.08M | – |
| Q1 FY2017 | Mar 31, 2017 | $50.39M | – |
| Q4 FY2016 | Dec 31, 2016 | $61.87M | – |
See a number that looks wrong?